Core Viewpoint - The article highlights the issue of misleading marketing practices in the fish oil supplement industry, particularly through live streaming platforms, where products are often falsely advertised as having high levels of beneficial ingredients like Omega-3, EPA, and DHA [1][3][11]. Group 1: Product Claims and Testing - A specific fish oil product, marketed as having over 95% Omega-3 content, was found to contain no detectable levels of EPA and DHA, indicating a significant discrepancy between claims and actual content [5][7]. - The product was falsely labeled as being produced by a reputable pharmaceutical company, while it was actually manufactured by a lesser-known entity [7][9]. Group 2: Regulatory Standards and Industry Practices - The current regulatory framework for fish oil products in China lacks stringent requirements, allowing for widespread false advertising and the sale of ordinary food products as health supplements [12][14]. - The absence of mandatory standards for EPA and DHA content in fish oil products contributes to the prevalence of misleading claims in the market [12][14]. Group 3: Consumer Protection and Recommendations - Experts emphasize that consumers should be cautious and prefer purchasing from reputable pharmacies or official online stores, and look for products with the "blue hat" health food label to minimize risks [14][16]. - The article also notes that the recommended daily intake of EPA and DHA for adults ranges from 250 mg to 2000 mg, highlighting the importance of these components for health [16][18]. Group 4: Broader Implications in the Market - The investigation revealed that a significant portion of products sold in live streaming sessions misled consumers regarding their health benefits, with 69 out of 100 monitored products found to have misleading information [31]. - The trend of consumers seeking healthier and more natural food options has led to an increase in misleading marketing practices, necessitating better regulation and consumer education [31].